Published 6 days ago • loading... • Updated 6 days ago

New 96pc accurate prostate cancer test backed by Chris Hoy

Summary

A new 96 per cent accurate prostate cancer test has been developed by scientists and backed by Olympic cycling champion Sir Chris Hoy. The “truly game-changing” test can diagnose prostate cancer to a very high level of accuracy and identify the disease’s aggression as well as its sub-type. Scientists at EDX Medical, the Cambridge-based digital diagnostic firm behind the initiative, said the test is more accurate than the existing protein-specific antigen (PSA) test offered by the NHS.

4 Articles

All

Left

Center

Right

Daily Mirror

New prostate cancer DNA test as NHS considers screening all men for the disease

Blood and urine tests developed for prostate cancer which have 96% accuracy after BBC food critic Giles Coren announced his own shock diagnosis

6 days ago·London, United Kingdom

Read Full Article

The Telegraph

New 96pc accurate prostate cancer test backed by Chris Hoy

The ‘truly game-changing’ test can diagnose the disease to a very high level of accuracy and identify aggression and sub-type

6 days ago·London, United Kingdom

Read Full Article

pharmatimes.com

Cambridge scientists develop 'super test' for prostate cancer

New test aims to revolutionise prostate cancer screening

6 days ago

Read Full Article

DirectorsTalk Interviews

EDX Medical develops new 'super test' for prostate cancer

EDX Medical Group plc (AQSE:EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announced today it has developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate personalised treatment for patients. The EDX test identifies the presence or absence of cancerous cells, …

6 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year